In BLCA cells, downregulation of METTL3 reduced m6A modification in PD-L1 mRNA, thereby decreasing its stabilization by IGF2BP1, which enhanced the cytotoxicity of CD8 + T cells against tumor cells [113]. The gene discussed is METTL3; the disease is neoplasm.